Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | FDPS | P14324 | 8/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 5/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CETP | P11597 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | UBE2N | P61088 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28434703 | 1.00 | LMNA (0.41) | LMNAFDPSGGPS1CYP2D6SPHK1 | |
| SCHEMBL18863212 | 1.00 | LMNA (0.41) | LMNAFDPSGGPS1CYP2D6SPHK1 | |
| SCHEMBL1890334 | 1.00 | LMNA (0.41) | LMNAFDPSGGPS1CYP2D6SPHK1 | |
| SCHEMBL5820256 | 1.00 | LMNA (0.41) | LMNAFDPSGGPS1CYP2D6SPHK1 | |
| SCHEMBL142854 | 1.00 | LMNA (0.41) | LMNAFDPSGGPS1CYP2D6SPHK1 | |
| SCHEMBL2226505 | 1.00 | LMNA (0.41) | LMNAFDPSGGPS1CYP2D6SPHK1 | |
| SCHEMBL5963212 | 1.00 | LMNA (0.41) | LMNAFDPSGGPS1CYP2D6SPHK1 | |
| SCHEMBL139952 | 1.00 | LMNA (0.41) | LMNAFDPSGGPS1CYP2D6SPHK1 | |
| SCHEMBL136611 | 1.00 | LMNA (0.41) | LMNAFDPSGGPS1CYP2D6SPHK1 | |
| SCHEMBL29064953 | 1.00 | LMNA (0.41) | LMNAFDPSGGPS1CYP2D6SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10638 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3419665-B1 | TREATMENT METHODS FOR FIBROSIS TARGETING SMOC2 | BRIGHAM & WOMENS HOSPITAL INC (US) | 2024-10-30 | — | — | EP | claimed |
| US-20240229029-A9 | COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-07-11 | — | — | US | claimed |
| US-20240141348-A1 | ALLELE SELECTIVE INHIBITION OF MUTANT C9ORF72 FOCI EXPRESSION BY DUPLEX RNAS TARGETING THE EXPANDED HEXANUCLEOTIDE REPEAT | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-05-02 | — | — | US | claimed |
| US-20240132889-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-04-25 | — | — | US | claimed |
| US-20200016264-A1 | NUCLEIC ACID OF FORMULA (I): GlXmGn, OR (II): ClXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT | CUREVAC AG (DE) | 2020-01-16 | — | — | US | claimed |
| US-10441653-B2 | Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvant | CUREVAC AG (DE) | 2019-10-15 | — | — | US | claimed |
| US-10260071-B2 | CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity | COLEY PHARMACEUTICAL GMBH (DE) | 2019-04-16 | — | — | US | claimed |
| US-20160348115-A1 | CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity | PFIZER INC. | 2016-12-01 | — | — | US | claimed |
| EP-2078080-B1 | CPG OLIGONUCLEOTIDE ANALOGS CONTAINING HYDROPHOBIC T ANALOGS WITH ENHANCED IMMUNOSTIMULATORY ACTIVITY | COLEY PHARM GMBH (DE) | 2015-06-17 | — | — | EP | claimed |
| US-20140163213-A1 | CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity | COLEY PHARMACEUTICAL GMBH (DE) | 2014-06-12 | — | — | US | claimed |
| US-20100166780-A1 | CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity | PFIZER INC | 2010-07-01 | — | — | US | claimed |
| US-20090324584-A1 | Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant | CUREVAC GMBH (DE) | 2009-12-31 | — | — | US | claimed |
| EP-2078080-A2 | CPG OLIGONUCLEOTIDE ANALOGS CONTAINING HYDROPHOBIC T ANALOGS WITH ENHANCED IMMUNOSTIMULATORY ACTIVITY | Coley Pharmaceuticals GmbH (DE) | 2009-07-15 | — | — | EP | claimed |
| EP-2046954-A2 | NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT | Curevac GmbH (DE) | 2009-04-15 | — | — | EP | claimed |
| WO-2009018332-A1 | SINGLE-STRANDED AND DOUBLE-STRANDED OLIGONUCLEOTIDES COMPRISING A METAL-CHELATING LIGAND | ALNYLAM PHARMACEUTICALS, INC. (US) | 2009-02-05 | — | — | WO | claimed |
| WO-2008068638-A2 | CPG OLIGONUCLEOTIDE ANALOGS CONTAINING HYDROPHOBIC T ANALOGS WITH ENHANCED IMMUNOSTIMULATORY ACTIVITY | COLEY PHARMACEUTICAL GMBH (DE) | 2008-06-12 | — | — | WO | claimed |
| WO-2008014979-A2 | NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT | CUREVAC GMBH (DE) | 2008-02-07 | — | — | WO | claimed |
| US-20070280929-A1 | ADJUVANT IN THE FORM OF A LIPID-MODIFIED NUCLEIC ACID | CUREVAC GMBH (DE) | 2007-12-06 | — | — | US | claimed |
| WO-2007095976-A2 | ADJUVANT IN THE FORM OF A LIPID-MODIFIED NUCLEIC ACID | CUREVAC GMBH (DE) | 2007-08-30 | — | — | WO | claimed |
| US-20060115461-A1 | Apparatus and system having dry gene silencing compositions | DHARMACON, INC. | 2006-06-01 | — | — | US | claimed |